Welcome!

News Feed Item

Plandai Biotechnology Management Discusses Progress of Company's Cannabis Extracts

NEW YORK, NY -- (Marketwired) -- 03/28/14 -- Last month Plandaí Biotechnology, Inc. (OTCQB: PLPL) closed a licensing agreement with Diego Pellicer, Inc. that will allow the company to use the Diego Pellicer name for its Phytofare™ cannabis extract in medical and pharmaceutical marijuana applications. Plandaí will produce the new Diego Pellicer Gold™ extracts in both capsules and cannabis oil (for vapor use) in Pheroid™ and non-Pheroid™ versions to appeal to the broadest range of medicinal consumers.

Stock Market Media Group (SMMG), a full service research and content development investor relations firm, asked Plandaí's management about the company's journey to introduce cannabis extracts to the market.

SMMG: Where is Plandai in the process of adding cannabis products?

Plandaí: "We are doing several things simultaneously. First, we're reviewing the various strains of cannabis and selecting one that we feel will have the best chemical profile for what we want to accomplish with the extract.

We're also working in Washington to ensure that we have live plant matter available for testing later in the year. Finally, we are engineering a CRS hydrodynamic processing and extraction system and constructing a laboratory in Washington that will make the initial extract for testing."

SMMG: What has been completed in the process and what is left to complete?

Plandaí: "The initial steps involved determining if we could even make a cannabis extract. This involved a review of the legal environment, the physical properties of the plant, and the chemical properties of the plant. We then needed to hire a small team that could 1) Select the correct strain, 2) Establish cultivation protocols, 3) Reach out to investigational institutions to begin lining up clinical trials, and 4) Adapt our current extraction system to be able to process cannabis. All of these things have happened.

We expect to finalize terms with a cultivation facility in the coming weeks so that we have suitable established plants in adequate quantities by this fall to begin making sample extract. Remember, we must use live plant material and we must use a specific and reproducible strain. We can't just go into a shop and buy dry leaf. Working with local growers, we need to document their cultivation techniques, fertilizer, etc. All of these things can impact the chemical profile. So, we need to manage the process to ensure that we have the correct chemical profile.

Concurrently, we will be building a small-scale lab so that we can produce our first cannabinoid extract. This will then need to be tested to get a chemical profile. We then need to test it for bioavailability and establish dosage parameters. Only then can we start testing for specific medical properties and benefits."

SMMG: What role will both the hydrodynamic sheering process and Pheroid® play in the production of extracts?

Plandaí: "The hydrodynamic sheering process is what breaks down and separates the plant structures, giving us increased bioavailability as well as allowing us to maximize the amount of phytonutrients we extract. All of our products will go through this process. The specific processing challenges we face with cannabis are releasing THC and CBD from the viscous cannabis oil and in the process reducing the articles to a high percentage of nano from the current ratio of 250-350mg. To achieve this, new formulated liquids will be used in the processing cycle.

The Pheroid® brings in certain additional properties which, depending on the individual may be considered advantageous or disadvantageous.

Essentially, the Pheroid® will entrap the cannabinoids until they reach the cells. This means that the THC will not metabolize in the blood stream, thus conceivably eliminating the psychoactive effects. We believe that we will be able to deliver a meaningful dosage of cannabinoids without the accompanying 'high.'

This will be ideal for patients with neural disorders and diseases. Some conditions require or prefer the metabolized THC and welcome the associated psychoactive effects. Thus, we expect to develop and test both a Pheroid® and non-Pheroid® version of the product."

SMMG: Where will these extracts be sold?

Plandaí: "We do not plan on having retail locations or selling directly to consumers. We are an ingredient manufacturer for nutraceutical and pharmaceutical applications. We will produce our extracts and then look to sell them to manufacturers of finished goods or into medicinal applications."

SMMG: What role, if any, will your South African plantation and manufacturing facility play in the future of your cannabis extract?

Plandaí: "Presently, South African law prohibits the cultivation of cannabis and furthermore it would be impossible to legally export or import any cannabis-based products or extracts. Our South Africa estate and factory is set up exclusively for processing our Phytofare™ Catechin Complex, which is made from green tea, though eventually we expect to also produce a citrus complex at this same facility. So, our South Africa operations will not be involved in any way for the foreseeable future. Until we are through with our research and animal trials, it is premature to speculate on when, if, or where we will produce a commercial cannabis extract, but we will only be involved if we can be assured that we are complying with all Federal and state laws.

As we recently announced, however, an appeal was made on our behalf to the South African legislature to grant Plandaí a special dispensation, or waiver, allowing us to produce and test a cannabinoid Phytofare™ extract for human clinical trials. In addition, legislation has recently been introduced in South Africa to permit medical marijuana research. Should this legislation pass, or should the government grant us special dispensation, it could open up the door to advancing medical research on an accelerated basis. We will know more in the coming months and will keep our shareholders apprised of any developments on this front."

About Stock Market Media Group

SMMG is a full service IR firm specializing in Research and Content Development. It offers a platform for corporate stories to unfold through the media with Reports, Interviews and Articles. SMMG is compensated for Plandaí articles, reports and interviews by a third party who reserves the right to sell securities at any time before, during, or after the publication of this article. To date, SMMG has received total compensation of $36,290, for content related to Plandaí. For more information and to read full disclaimers and disclosures: www.stockmarketmediagroup.com/disclaimer.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact:
Stock Market Media Group
Email Contact

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
It is one thing to build single industrial IoT applications, but what will it take to build the Smart Cities and truly society changing applications of the future? The technology won’t be the problem, it will be the number of parties that need to work together and be aligned in their motivation to succeed. In his Day 2 Keynote at @ThingsExpo, Henrik Kenani Dahlgren, Portfolio Marketing Manager at Ericsson, discussed how to plan to cooperate, partner, and form lasting all-star teams to change the...
SYS-CON Events announced today that delaPlex will exhibit at SYS-CON's @CloudExpo, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. delaPlex pioneered Software Development as a Service (SDaaS), which provides scalable resources to build, test, and deploy software. It’s a fast and more reliable way to develop a new product or expand your in-house team.
For organizations that have amassed large sums of software complexity, taking a microservices approach is the first step toward DevOps and continuous improvement / development. Integrating system-level analysis with microservices makes it easier to change and add functionality to applications at any time without the increase of risk. Before you start big transformation projects or a cloud migration, make sure these changes won’t take down your entire organization.
SYS-CON Events announced today that IoT Now has been named “Media Sponsor” of SYS-CON's 20th International Cloud Expo, which will take place on June 6–8, 2017, at the Javits Center in New York City, NY. IoT Now explores the evolving opportunities and challenges facing CSPs, and it passes on some lessons learned from those who have taken the first steps in next-gen IoT services.
Updating DevOps to the latest production data slows down your development cycle. Probably it is due to slow, inefficient conventional storage and associated copy data management practices. In his session at @DevOpsSummit at 20th Cloud Expo, Dhiraj Sehgal, in Product and Solution at Tintri, will talk about DevOps and cloud-focused storage to update hundreds of child VMs (different flavors) with updates from a master VM in minutes, saving hours or even days in each development cycle. He will also...
Extreme Computing is the ability to leverage highly performant infrastructure and software to accelerate Big Data, machine learning, HPC, and Enterprise applications. High IOPS Storage, low-latency networks, in-memory databases, GPUs and other parallel accelerators are being used to achieve faster results and help businesses make better decisions. In his session at 18th Cloud Expo, Michael O'Neill, Strategic Business Development at NVIDIA, focused on some of the unique ways extreme computing is...
The explosion of new web/cloud/IoT-based applications and the data they generate are transforming our world right before our eyes. In this rush to adopt these new technologies, organizations are often ignoring fundamental questions concerning who owns the data and failing to ask for permission to conduct invasive surveillance of their customers. Organizations that are not transparent about how their systems gather data telemetry without offering shared data ownership risk product rejection, regu...
SYS-CON Events announced today that WineSOFT will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Based in Seoul and Irvine, WineSOFT is an innovative software house focusing on internet infrastructure solutions. The venture started as a bootstrap start-up in 2010 by focusing on making the internet faster and more powerful. WineSOFT’s knowledge is based on the expertise of TCP/IP, VPN, SSL, peer-to-peer, mob...
The Internet of Things can drive efficiency for airlines and airports. In their session at @ThingsExpo, Shyam Varan Nath, Principal Architect with GE, and Sudip Majumder, senior director of development at Oracle, discussed the technical details of the connected airline baggage and related social media solutions. These IoT applications will enhance travelers' journey experience and drive efficiency for the airlines and the airports.
With billions of sensors deployed worldwide, the amount of machine-generated data will soon exceed what our networks can handle. But consumers and businesses will expect seamless experiences and real-time responsiveness. What does this mean for IoT devices and the infrastructure that supports them? More of the data will need to be handled at - or closer to - the devices themselves.
SYS-CON Events announced today that Dataloop.IO, an innovator in cloud IT-monitoring whose products help organizations save time and money, has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Dataloop.IO is an emerging software company on the cutting edge of major IT-infrastructure trends including cloud computing and microservices. The company, founded in the UK but now based in San Fran...
Big Data, cloud, analytics, contextual information, wearable tech, sensors, mobility, and WebRTC: together, these advances have created a perfect storm of technologies that are disrupting and transforming classic communications models and ecosystems. In his session at @ThingsExpo, Erik Perotti, Senior Manager of New Ventures on Plantronics’ Innovation team, provided an overview of this technological shift, including associated business and consumer communications impacts, and opportunities it m...
The financial services market is one of the most data-driven industries in the world, yet it’s bogged down by legacy CPU technologies that simply can’t keep up with the task of querying and visualizing billions of records. In his session at 20th Cloud Expo, Jared Parker, Director of Financial Services at Kinetica, will discuss how the advent of advanced in-database analytics on the GPU makes it possible to run sophisticated data science workloads on the same database that is housing the rich inf...
In his keynote at @ThingsExpo, Chris Matthieu, Director of IoT Engineering at Citrix and co-founder and CTO of Octoblu, focused on building an IoT platform and company. He provided a behind-the-scenes look at Octoblu’s platform, business, and pivots along the way (including the Citrix acquisition of Octoblu).
"delaPlex is a software development company. We do team-based outsourcing development," explained Mark Rivers, COO and Co-founder of delaPlex Software, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.